Future Tech: Almost Here, Round-the-corner Future Technology Podcast

Josep Bassaganya-Riera, DVM, PhD, founder, Chairman and CEO of Landos Biopharma, delivers a fact-filled overview of his company’s work, developing safer therapeutics for autoimmune disease. Dr. Bassaganya-Riera has received numerous research grants from a wide variety of science and health institutions, including the National Institutes of Health, the United States Department of Agriculture (USDA), as well as many industrial corporations. Dr. Bassaganya-Riera holds the title of Principal Investigator and Director for the Modeling Immunity to Enteric Pathogens (MIEP) project, which investigates the various immunoregulatory mechanisms underlying infections with certain gut pathogens by introducing mathematical systems to current mucosal immunology. Dr. Bassaganya-Riera discusses his work with Landos Biopharma, an emerging biotech company that is already an integral player in the development of groundbreaking oral treatments for patients who suffer from autoimmune diseases. He discusses the unmet needs in Croh